| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |